About Us
- Five year old Leif Anderson suffered a spontaneous retinal detachment. His father, Douglas committed to develop an advanced retinal imaging system.
- Plus 180 project spun out of Crombie Anderson Associates
- Optos was registered with the name Zenoplan Ltd which changed to Besca Ltd then became Optos Ltd.
- The original napkin sketch which lead to the technological breakthrough which lead to our first patent application
- Some very supportive Investors Mike Rutterford, Douglas Anderson, Barry Sealey
- First Plus 180 displayed at the American Academy of Ophthalmology
- Original conceptual operations and design for the first ultra-widefield retinal imaging device
- Panoramic 200 is granted a patent and approved for sale in Europe
- US Headquarters opens
- Panoramic 200 launched at the American Academy of Optometry and the American Academy of Ophthalmology
- Douglas with Her Majesty Queen Elizabeth after receiving the Order of the British Empire in recognition of his distinguished service to the sciences
- Panoramic 200 becomes commercially available in the US, Canada and Germany
- The first P200 sold to Louis Frank, OD
- Mirren Stevens, first baby to be imaged
- HRH The Princess Royal, visits Optos Global Headquarters
- Optos opened London Stock Exchange and celebrated admission and first day of unconditional trading
- Optos announced 2000th North American Customer
- Optos named winner of the 2006 Royal Academy MacRobert Award for Innovation in Engineering
- Lenscrafters became a new corporate account
- Optos awarded the 2007 Queen’s Award for Enterprise
- 10 millionth optomap patient imaged
- Full release of P200MA in March
- P200C launched in April
- Optos named European Inventor of the Year
- Optos acquired Opto Global
- 200Dx introduced into Optometry
- 200Tx introduced into Ophthalmology
- Optos began the Lean Journey for manufacturing
- Daytona introduced
- 30 millionth optomap patient imaged
- Optos acquired Opko Instrumentation for OCT technology
- Optos won 2nd place 2011 Best Technology PLC Award
- Scottish Business Achievement Award Trust presented to CEO Roy Davis by HRH The Princess Royal
- Daytona began shipping in the US and UK
- OPSM contract signed
- Won the prestigious 2012 Scottish Enterprise Life Sciences Business Leadership Award
- Results of Joslin Diabetes Study stated that optomap is equivalent to the ETDRS Gold Standard
- OptosAdvance Software launched
- 40 millionth optomap patient imaged
- 2nd Joslin study indicated patients with predominantly peripheral lesions had a 4 times increased risk of progressing to a more severe level of retinopathy
- Visionworks became a new corporate account
- California revealed at the American Academy of Ophthalmology
- Highest level of installations in one year, 1,271 which represented a 24% growth
- Optos won Technology of the Year award at European Mediscience Awards
- ProView™ software launched
- Instrumentarium became a new corporate account in Finland
- Optos acquired by Nikon Corporation
- Over 50 million people have had an optomap retinal image and more than 10,000 devices are installed worldwide
- Daytona plus launched
- Optos display installed in the National Museum of Scotland
- Nikon and Verily establish strategic alliance to develop machine learning-enabled solutions for diabetes-related eye disease
- Optos celebrates their 25th anniversary of incorporation
- OPERA study published demonstrating 97% of AMD patients have perihpheral drusen
- Monaco Launched
- DRCR Protocol AA study publication validating UWF equivelant to ETDRS
- OptosCloud launched in the US
- Optical Supplier of the Year (Optician Awards)
- The Queen's award for Enterprise for Innovation for California
- Scottish Engineering President's Award for Excellence 2019
- Over 16,000 devices installed
- Over 150 Million patients imaged
- Silverstone launched
- More than 1,000 clinical publications
- Ultra-widefield Definition Paper published
- ARVO 2019 - record number of publications (124)
- OptosCloud launched in Canada and EU
- For the second year running, Optical Supplier of the Year (Optician Awards)
- Monaco segementation launched in EU, Canada, Australia and New Zealand
of a Brand
Optos was founded and incorporated in 1992 by Douglas Anderson after his young son went blind in one eye after a retinal detachment was detected too late. Although his son was having regular eye exams, routine exams were uncomfortable, especially for a child, which made it impossible for the doctor to conduct a complete exam and view the entire retina. Anderson set out to commercialize a patient-friendly retinal image product that encompassed a digital widefield image of the retina in a single capture.
We are recognized as a leading provider of devices to eye care professionals for improved patient care. Our core devices produce ultra-widefield (UWF™), high resolution optomap images of approximately 82% or 200◦ of the retina, something no other device is capable of doing in a single capture. An optomap image provides a bigger picture and more clinical information that facilitates the early detection, management and effective treatment of disorders and diseases evidenced in the retina such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration.
Optos is committed to utilizing the latest technology to manufacture new products and software that support optomap as a standard of care, therefore, helping eye care professionals around the world save sight and lives. Furthermore, the company continues to strengthen its clinical evidence and expand its disease indications to demonstrate the importance of imaging the entire retina.
In addition, our range of ultra-widefield retinal imaging devices, support different customer segments and patient needs such as wellness screening carried out by optometrists in primary care settings or, more exacting imaging in secondary care practices that are clinically managing a patient base with advanced ocular disease. Our most advanced imaging devices for disease management and treatment support ophthalmologists and retinal specialists in the medical care market.
Optos was financed through angel and venture capital investors until its flotation on the London Stock Exchange in February 2006. In May 2015, Optos was acquired by Nikon. In August of 2017, Optos celebrated the 25th anniversary of our founding and of ultra-widefield retinal imaging.
Leadership Team
Meet the duo leading Optos into the future.
Meet Rob and QuinnCareers
Optos looks for leaders - people who want to take charge of their careers, whatever their role. Become a part of the team at Optos that is enabling eyecare professionals to save sight and save lives.
Find a Career at OptosContact Media Relations
Optos, Inc.
500 Nickerson Road, Suite 201
Marlborough, MA 01752
USA
800-854-3039
mediarelations@optos.com
News & Press Releases
Optos is in the news! Find out the latest on what is happening at Optos, our key clinical research updates, and news on local events, local press, and product news.
Read MoreCorporate Information
Section dedicated to company policies, statements and agreements.
Go to Documents